Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > EY sees bolt-ons in the single to double digit billions now

<< Previous

Bullboard Posts

Next >>

Comment by Buckhenryon Sep 23, 2022 5:18pm

103 Views

Post# 34983207

RE:RE:RE:EY sees bolt-ons in the single to double digit billions now

let's see... that's about the 15th company on the hunt for an acquisition that's been posted on here. are you folks over optimistic or just like to post frivolous junk or you can't face reality. im in this for the long haul but my gosh folks... you get all icing and no cake here.

<< Previous

Bullboard Posts

Next >>

Casa Minerals receives drill permit for Arsenault Project